Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Level of Scientific Evidence Underlying Recommendations from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Hematologic Malignancies: Are We Moving Forward?

Aakash Desai, MD, Harry E Fuentes, MD MS, Sri Harsha Tella, MD, Caleb J Scheckel, DO, Thejaswi Poonacha, MD, Ronald S. Go, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-138376

Published: 2020

Journal Articles

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Antonious Hazim, Gordon Ruan, MD, Aishwarya Ravindran, MBBS, Jithma P. Abeykoon, MD, Caleb J Scheckel, DO, Robert Vassallo, MD, Jay Ryu, MD, W. Oliver Tobin, MB BCh, Matthew Koster, MD, Nabila Bennani, MD, Karen Rech, MD, Jason R Young, MD, Mithun Vinod Shah, MD PhD, Gaurav Goyal, MD, Ronald S. Go, MD

Blood (2020) 136 (Supplement 1): 45.

https://doi.org/10.1182/blood-2020-136861

Published: 2020

Journal Articles

Thrombophilia Testing Practices: The Mayo Clinic Experience

Caleb J Scheckel, DO, Rajiv K. Pruthi, M.B.B.S, Ariela L. Marshall, MD, Aneel A. Ashrani, MD MS, Dong Chen, MD, PhD, Nahla M. Heikal, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-141633

Published: 2020

Journal Articles

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Caleb J Scheckel, DO, Didar Yanardag Acik, MD, Aneel A. Ashrani, MD MS, C. Christopher Hook, MD, Lindsey Ann Kluck, APRN, CNP, MSN, Ariela L. Marshall, MD, Rajiv K. Pruthi, MBBS, Aishwarya Ravindran, MBBS, Mithun Vinod Shah, MD PhD, Alexandra Wolanskyj, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 4815.

https://doi.org/10.1182/blood-2019-127306

Published: 2019

Journal Articles

Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC

Caleb J Scheckel, DO, Megan Meyer, MD, Lanyu Mi, MS, James L. Slack, MD, Pierre Noel, MD, Jose F. Leis, MD PhD, Lisa Z. Sproat, James M. Foran, MD, Aref Al-Kali, MD, Rhett P. Ketterling, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 2678.

https://doi.org/10.1182/blood-2018-99-114655

Published: 2018

Journal Articles

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Caleb J Scheckel, DO, Jeffrey Alan Betcher, BSPharm, RPh, Lisa Sproat, MD MSW, Nandita Khera, MD, James L. Slack, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Raoul Tibes, Lanyu Mi, MS, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 5057.

https://doi.org/10.1182/blood.V130.Suppl_1.5057.5057

Published: 2017

Journal Articles

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Caleb J Scheckel, DO, Jeffrey Alan Betcher, BSPharm, RPh, Lisa Sproat, MD MSW, Raoul Tibes, James L. Slack, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Lanyu Mi, MS, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 5058.

https://doi.org/10.1182/blood.V130.Suppl_1.5058.5058

Published: 2017

NARROW

Level of Scientific Evidence Underlying Recommendations from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Hematologic Malignancies: Are We Moving Forward?

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Thrombophilia Testing Practices: The Mayo Clinic Experience

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Level of Scientific Evidence Underlying Recommendations from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Hematologic Malignancies: Are We Moving Forward?

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Thrombophilia Testing Practices: The Mayo Clinic Experience

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only